Traditionally, therapeutic development has focused on minute molecules, but peptide alliances are progressively receiving traction. This innovative approach utilizes combining short amino acid chains with complementary biological modalities to tackle intricate illness pathways. By leveraging the distinctive properties of amino acid sequences – su